CIK: 0001615982
Total reported value
$2.7B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CNST | Constellation Pharmaceutical | Stock-Other | 28.90% | — | — | |
| 2 | TREUR | Trillium Therapeutics INC | Stock-Other | 13.15% | — | — | |
| 3 | ALT | Altimmune INC | Stock-Other | 11.54% | — | — | |
| 4 | RLMD | Relmada Therapeutics INC | Stock-Other | 7.16% | +1.26% | NEW | |
| 5 | SURFUSD | Surface Oncology INC | Stock-Other | 6.09% | — | — | |
| 6 | KROS | Keros Therapeutics INC | Stock-Other | 6.04% | — | — | |
| 7 | VXRT | Vaxart INC | Stock-Other | 5.86% | — | — | |
| 8 | ✓ | Myovant Sciences LTD | Stock-Other | 4.17% | — | — | |
| 9 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 3.48% | — | -11.94% | |
| 10 | NARIUSD | Inari Medical INC | Stock-Other | 2.73% | — | — | |
| 11 | KURA | Kura Oncology INC | Stock-Other | 2.24% | — | — | |
| 12 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 2.22% | — | — | |
| 13 | ✓ | Avadel Pharmaceuticals PLC | Stock-Other | 2.05% | — | — | |
| 14 | ADAPY | Adaptimmune Therapeutics-adr | Stock-Other | 1.87% | — | — | |
| 15 | ETNBGBP | 89bio INC | Stock-Other | 1.39% | — | -69.42% | |
| 16 | ✓ | Sierra Oncology INC Com | Stock-Other | 1.10% | — | -22.84% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TREUR | Trillium Therapeutics INC | +5.7% | — | Unchanged |
| 2 | MRNSUSD | Marinus Pharmaceuticals INC | -0.1% | -11.94% | Trim |
| 3 | ✓ | Sierra Oncology INC Com | -0.2% | -22.84% | Trim |
| 4 | ✓ | Avadel Pharmaceuticals PLC | -0.2% | — | Unchanged |
| 5 | RLMD | Relmada Therapeutics INC | -0.6% | -20.69% | Trim |
| 6 | ETNBGBP | 89bio INC | -5.1% | -69.42% | Trim |
| 7 | CNST | Constellation Pharmaceutical | -5.3% | — | Unchanged |
| 8 | ALT | Altimmune INC | — | NEW | New buy |
| 9 | AXSM | Axsome Therapeutics INC | — | EXIT | Sold out |
| 10 | SURFUSD | Surface Oncology INC | — | NEW | New buy |
| 11 | KROS | Keros Therapeutics INC | — | NEW | New buy |
| 12 | VXRT | Vaxart INC | — | NEW | New buy |
| 13 | ✓ | Inovio Pharmaceuticals INC | — | EXIT | Sold out |
| 14 | TXG | 10x Genomics Inc-class A | — | EXIT | Sold out |
| 15 | ✓ | Myovant Sciences LTD | — | NEW | New buy |
| 16 | ✓ | Mersana Therapeutics INC | — | EXIT | Sold out |
| 17 | NARIUSD | Inari Medical INC | — | NEW | New buy |
| 18 | ✓ | Veralto CORP | — | EXIT | Sold out |
| 19 | ADVMCHF | Adverum Biotechnologies INC | — | EXIT | Sold out |
| 20 | KURA | Kura Oncology INC | — | NEW | New buy |
| 21 | SNDX | Syndax Pharmaceuticals INC | — | NEW | New buy |
| 22 | OPHTEUR | Iveric Bio INC | — | EXIT | Sold out |
| 23 | ADAPY | Adaptimmune Therapeutics-adr | — | NEW | New buy |
| 24 | SPRO | Spero Therapeutics INC | — | EXIT | Sold out |
| 25 | PTGX | Protagonist Therapeutics INC | — | EXIT | Sold out |